BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 46 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $7,150,000 | -7.6% | 6,409,000 | -8.2% | 0.02% | -4.0% |
| Q2 2017 | $7,735,000 | +5.9% | 6,980,000 | +8.0% | 0.02% | +13.6% |
| Q1 2017 | $7,301,000 | +6.4% | 6,465,000 | +5.3% | 0.02% | 0.0% |
| Q4 2016 | $6,864,000 | +0.7% | 6,139,000 | +8.0% | 0.02% | 0.0% |
| Q3 2016 | $6,815,000 | +344.6% | 5,682,000 | +311.7% | 0.02% | +266.7% |
| Q2 2016 | $1,533,000 | -55.0% | 1,380,000 | -53.0% | 0.01% | -62.5% |
| Q1 2016 | $3,403,000 | -72.0% | 2,938,533 | -68.9% | 0.02% | -71.9% |
| Q4 2015 | $12,137,000 | +3.2% | 9,454,000 | +3.8% | 0.06% | -1.7% |
| Q3 2015 | $11,766,000 | +106.0% | 9,108,000 | +145.8% | 0.06% | +114.8% |
| Q2 2015 | $5,712,000 | +42.0% | 3,706,000 | +37.1% | 0.03% | +50.0% |
| Q1 2015 | $4,022,000 | +22.4% | 2,703,000 | -1.3% | 0.02% | +28.6% |
| Q4 2014 | $3,287,000 | +13.4% | 2,738,000 | 0.0% | 0.01% | +16.7% |
| Q3 2014 | $2,899,000 | -5.6% | 2,738,000 | -7.7% | 0.01% | -7.7% |
| Q2 2014 | $3,070,000 | -39.5% | 2,968,000 | -35.9% | 0.01% | -35.0% |
| Q1 2014 | $5,073,000 | -13.5% | 4,630,000 | -16.4% | 0.02% | -16.7% |
| Q4 2013 | $5,864,000 | – | 5,536,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|